Acadia Pharmaceuticals Inc
Nasdaq · Healthcare · Pharmaceutical Preparations · San Diego, CA
ACAD chart
What traders are saying about $ACAD
Latest postsAcadia Pharmaceuticals Inc news
- Acadia Pharmaceuticals (ACAD) Shares Rise After Key Patent Court Hearing
GuruFocus ·
- ACADIA Pharmaceuticals Inc. (ACAD) Stock Price | Live Quotes & Charts | NASDAQ
Timothy Sykes ·
- Is Acadia Pharmaceuticals (NASDAQ:ACAD) Down 22.28% at a 52-Week Low Despite a Quarterly Beat?
kalkine.ca ·
- One holder reports 7.65 million Acadia Pharmaceuticals (ACAD) shares.
Stock Titan ·
- What Has The Market Missed In Acadia Pharmaceuticals Stock’s Drop?
Trefis ·
- Acadia Pharmaceuticals Expects Federal Circuit Decision In Nuplazid Patent Appeal In First Half Of 2027
TradingView ·
- Acadia Pharmaceuticals Fell While Sales Rose
Yahoo Finance ·
- Acadia Pharmaceuticals Comments on Federal Circuit Oral Argument in NUPLAZID® Formulation Patent Appeal
Yahoo Finance ·
- A Parkinson’s psychosis drug could have patent protection until 2038—or 2030, depending on an appeal.
Stock Titan ·
- Acadia Pharmaceuticals (ACAD) Stock Still Looks Like A Bargain Today
Yahoo Finance ·
- Why Is Acadia Pharmaceuticals (ACAD) Presenting New Remlifanserin Data Worth Watching?
Simply Wall St ·
- Acadia Pharmaceuticals (ACAD) Cuts 2026 R And D Guidance, Is It Still 46% Undervalued?
Yahoo Finance ·
Acadia Pharmaceuticals Inc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $1.07B | $957.8M | $726.4M | $517.2M |
| Net income | $391.0M | $226.0M | -$61.0M | -$214.0M |
| Diluted EPS | $2.30 | $1.36 | $-0.37 | $-1.34 |
| Total assets (year end) | $1.56B | $1.19B | $749.0M | $587.8M |
| Cash and equivalents (year end) | $177.7M | $319.6M | $188.7M | $114.8M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Acadia Pharmaceuticals Inc
- Ticker
- ACAD (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1070494
Frequently asked questions
What exchange is Acadia Pharmaceuticals Inc listed on?
Acadia Pharmaceuticals Inc trades on the Nasdaq under the ticker symbol ACAD.
What industry is Acadia Pharmaceuticals Inc in?
Acadia Pharmaceuticals Inc is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Acadia Pharmaceuticals Inc headquartered?
Acadia Pharmaceuticals Inc's business address on file with the SEC is in San Diego, CA.
When does Acadia Pharmaceuticals Inc's fiscal year end?
Acadia Pharmaceuticals Inc's fiscal year ends on December 31.
How much revenue did Acadia Pharmaceuticals Inc report?
Acadia Pharmaceuticals Inc reported $1.07B in revenue for calendar year 2025, according to its SEC filings.